Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Asthma
- Study Title
- A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma
- Teva Identifier
- ABS-AS-201
- ClinicalTrials.gov Identifier
- NCT01058863
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 02/01/2010 - 06/01/2010
- Phase
- Phase 2
